Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIFAMPIN Cause Clostridium difficile colitis? 55 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Clostridium difficile colitis have been filed in association with RIFAMPIN (Rifampin). This represents 0.4% of all adverse event reports for RIFAMPIN.

55
Reports of Clostridium difficile colitis with RIFAMPIN
0.4%
of all RIFAMPIN reports
16
Deaths
47
Hospitalizations

How Dangerous Is Clostridium difficile colitis From RIFAMPIN?

Of the 55 reports, 16 (29.1%) resulted in death, 47 (85.5%) required hospitalization, and 13 (23.6%) were considered life-threatening.

Is Clostridium difficile colitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIFAMPIN. However, 55 reports have been filed with the FAERS database.

What Other Side Effects Does RIFAMPIN Cause?

Drug ineffective (1,238) Drug reaction with eosinophilia and systemic symptoms (1,049) Drug interaction (735) Pyrexia (735) Acute kidney injury (684) Drug-induced liver injury (684) Off label use (640) Condition aggravated (597) Nausea (572) Paradoxical drug reaction (570)

What Other Drugs Cause Clostridium difficile colitis?

CYCLOPHOSPHAMIDE (717) PREDNISONE (619) DEXAMETHASONE (575) METHOTREXATE (562) ETOPOSIDE (503) CYTARABINE (489) VINCRISTINE (482) LENALIDOMIDE (388) METHYLPREDNISOLONE (385) CIPROFLOXACIN (378)

Which RIFAMPIN Alternatives Have Lower Clostridium difficile colitis Risk?

RIFAMPIN vs RIFAMYCIN RIFAMPIN vs RIFAPENTINE RIFAMPIN vs RIFAXIMIN RIFAMPIN vs RILMENIDINE RIFAMPIN vs RILONACEPT

Related Pages

RIFAMPIN Full Profile All Clostridium difficile colitis Reports All Drugs Causing Clostridium difficile colitis RIFAMPIN Demographics